WASHINGTON, April 16 -- Bureau of Industry and Security has issued a notice called: Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients.
The notice was published in the Federal Register on April 16 by Eric Longnecker, Deputy Assistant Secretary for Technology Security.
Summary: The Secretary of Commerce initiated an investigation to determine the effects on the national security of imports of pharmaceuticals and pharmaceutical ingredients, including finished drug products, medical countermeasures, critical inputs such as active pharmaceutical ingredients, and key starting materials, and derivative products of those items. This investigation has b...